Lupin Latest News

  1. Lupin has informed that the company will be participating in the J P Morgan Global Healthcare Conference to be held on Tuesday, January 12, 2021.
    Date:11-01-2021
  2. Lupin has received tentative approval for its Empagliflozin and Metformin Hydrochloride ER Tablets
    Date:08-01-2021
  3. Lupin has informed that it has enclosed a Press Release on 7th January 2021, as regards receipt of tentative USFDA approval for the Company's Empagliflozin and Metformin Hydrochloride Extended-Release (ER) Tablets, 5 mg/10...

    Date:07-01-2021
  4. The product will be manufactured at Lupin's Nagpur facility in India
    Date:07-01-2021
  5. BCPL Railway Infrastructure has received a LoA from Howrah Division – Electrical, Eastern Railway
    Date:07-01-2021
  6. Sulfamethoxazole and Trimethoprim Oral Suspension USP, 200 mg/40 mg per 5 mL, is indicated for the treatment and prevention of a wide variety of bacterial infections
    Date:06-01-2021
  7. Mycophenolate Mofetil Tablets USP, 500 mg, are the generic equivalent of CellCept Tablets of Roche Palo Alto LLC
    Date:29-12-2020
  8. Meloxicam Capsules (RLD: Vivlodex) had an annual sales of approximately $ 11 million in the U.S. (IQVIA MAT October 2020)
    Date:28-12-2020
  9. Lupin has informed that it has enclosed a Press Release on 28th December 2020 as regards the launch by the Company of Meloxicam Capsules, 5 mg, and 10 mg, having received an approval from the US FDA, titled ‘Lupin launche...

    Date:28-12-2020
  10. Meloxicam Capsules (RLD: Vivlodex) had an annual sales of approximately $ 11 million in the U.S. (IQVIA MAT October 2020)
    Date:28-12-2020
Return to Top
Puchho Befikar